ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

No reported Income Tax Expense figures are available to summarize.

Income Tax Expense history

Currency unavailable · from the income statement

No Income Tax Expense data reported for this period type.

Income Tax Expense vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Income Tax Expense for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRQRProQR Therapeutics N.V.LTM Mar 2026€18.99K EUR+109.5%-42.5%0.1%
SLNSilence Therapeutics plcLTM Mar 2026$14.71K USD—-73.0%1.6%
MGTXMeiraGTx Holdings plcLTM Mar 2026$0 USD——0.0%
PRMEPrime Medicine, Inc.LTM Mar 2026$0 USD+100.0%—0.0%
WVEWave Life Sciences Ltd.LTM Mar 2026$0 USD——0.0%
BNTCBenitec Biopharma Inc.LTM Mar 2026$0 USD———
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$0 USD+100.0%—0.0%
RNAAtrium Therapeutics, Inc.FY2025-$142K USD——0.8%
STOKStoke Therapeutics, Inc.LTM Mar 2026-$1.28M USD-200.0%—4.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+100.0%-57.8%0.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.